Ana I. Rodríguez‐Pérez

Author

Universidade de Santiago de Compostela ORCID

Also Known As

A Rodriguez-Perez, A Rodríguez-Pérez, A. I. Rodriguez-Perez, A. I. Rodríguez-Perez, A. Rodriguez-Perez, A.I. Rodríguez-Pérez, A.I. Rodríguez‐Pérez, AI Rodríguez-Perez, Ana I Rodriguez-Perez, Ana I Rodríguez-Perez

100

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Universidade de Santiago de Compostela Biomedical Research Networking Center on Neurodegenerative Diseases Center for Research in Molecular Medicine and Chronic Diseases Universidad de Navarra Universitat de Barcelona

About

Ana I. Rodríguez‐Pérez is an author at Universidade de Santiago de Compostela specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	25	1.7K
2	Social Sciences	4	4	297
3	Engineering	2	2	134
4	Health Sciences	1	1	63
5	Biochemistry	1	1	16

Ana I. Rodríguez‐Pérez

Publications

Citations

H-Index

Page 1

	Year	Citations
The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease Belen Joglar, Jannette Rodrı́guez-Pallares, Ana I. Rodríguez‐Pérez, Journal of Neurochemistry Brain AngiotensinRedox BiologyOxidative StressNeuroinflammationInflammation	2009	188
Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease Pablo Garrido‐Gil, Belen Joglar, Ana I. Rodríguez‐Pérez, Journal of Neuroinflammation	2012	132
Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models Pablo Garrido‐Gil, Ana I. Rodríguez‐Pérez, Antonio Dominguez‐Meijide, Molecular Neurobiology Disease ModelsParkinson ’Gut LesionsNeurologyNeuroscience	2018	125
New Cyclodextrin Hydrogels Cross-Linked with Diglycidylethers with a High Drug Loading and Controlled Release Ability Carmen Rodríguez‐Tenreiro, Carmen Alvarez‐Lorenzo, Ana I. Rodríguez‐Pérez, Pharmaceutical Research Biopolymer GelHydrogelsEngineeringPolymer-drug ConjugateHigh Drug Loading	2005	117
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and levodopa-induced dyskinesia Gemma Navarro, Dasiel O. Borroto‐Escuela, Edgar Angelats, Brain Behavior and Immunity Neurodegenerative DiseasesAlzheimer's DiseaseCb2 ReceptorsActivated MicrogliaLevodopa-induced Dyskinesia	2017	117
Dopamine modulates astroglial and microglial activity via glial renin-angiotensin system in cultures Antonio Dominguez‐Meijide, Ana I. Rodríguez‐Pérez, Carmen Díaz-Ruiz, Brain Behavior and Immunity NeurophysiologyMedicinePharmacologyMicroglial ActivityNeuropharmacology	2017	114
Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors Begoña Villar‐Cheda, Antonio Dominguez‐Meijide, Belen Joglar, Neurobiology of Disease Angiotensin Type 1MedicinePharmacologyDopaminergic Neuron DeathCell Death	2012	104
Aging-related changes in the nigral angiotensin system enhances proinflammatory and pro-oxidative markers and 6-OHDA-induced dopaminergic degeneration Begoña Villar‐Cheda, Rita Valenzuela, Ana I. Rodríguez‐Pérez, Neurobiology of Aging InflammationAgingLongevityMedicinePhysiology	2010	97
Interaction between <scp>NADPH</scp>‐oxidase and <scp>R</scp>ho‐kinase in angiotensin <scp>II</scp>‐induced microglial activation Ana I. Rodríguez‐Pérez, Ana Borrajo, Jannette Rodrı́guez-Pallares, Glia	2014	96
Estradiol sustained release from high affinity cyclodextrin hydrogels☆ Carmen Rodríguez‐Tenreiro, Carmen Alvarez‐Lorenzo, Ana I. Rodríguez‐Pérez, European Journal of Pharmaceutics and Biopharmaceutics PharmacologyCyclodextrin ProductionMedicineDrug Delivery Systems	2006	95

Page 1